Xeris Biopharma Holdings, Inc. (XERS) Debt by Year
Xeris Biopharma Holdings, Inc. carried $220.3M in long-term debt against $111.0M in cash and equivalents at the end of fiscal year 2025. This represents an increase of 1.5% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Xeris Biopharma Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
XERS Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
XERS Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $188.8M-13.6% | $221.2M+1.6% | $220.3M+1.5% | $219.5M+1.5% | $218.6M-5.1% | $217.8M-5.2% | $217.0M+13.7% | $216.2M+13.6% | $230.5M+22.5% | $229.7M+22.4% | $190.9M+2.1% | $190.4M+37.5% |
| Cash & Equivalents | $121.7M+105.4% | $111.8M+91.2% | $111.0M+55.0% | $91.6M+54.6% | $59.3M+2.9% | $58.4M-6.8% | $71.6M+6.2% | $59.2M+28.4% | $57.6M+24.8% | $62.7M+23.0% | $67.4M-44.7% | $46.1M-45.1% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Xeris Biopharma Holdings, Inc. financials
Frequently Asked Questions
What was Xeris Biopharma Holdings, Inc.'s long-term debt in fiscal year 2025?
Xeris Biopharma Holdings, Inc. carried $220.3M in long-term debt against $111.0M in cash and equivalents at the end of fiscal year 2025.
How fast is Xeris Biopharma Holdings, Inc.'s long-term debt growing?
Xeris Biopharma Holdings, Inc. (XERS) long-term debt rose by 1.5% year over year, from $217.0M to $220.3M in fiscal year 2025.
How has Xeris Biopharma Holdings, Inc.'s long-term debt changed over the years?
Across the 6 fiscal years this page covers, Xeris Biopharma Holdings, Inc. (XERS) long-term debt went from $87.0M in fiscal year 2020 to $220.3M in fiscal year 2025.
What was Xeris Biopharma Holdings, Inc.'s long-term debt in the most recent quarter?
Xeris Biopharma Holdings, Inc. (XERS) reported $188.8M in long-term debt in Q2 2026. This represents a decrease of 13.6% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Xeris Biopharma Holdings, Inc. (XERS) reported on that line in every period on record.